These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37662937)

  • 1. Human T cells loaded with superparamagnetic iron oxide nanoparticles retain antigen-specific TCR functionality.
    Pfister F; Dörrie J; Schaft N; Buchele V; Unterweger H; Carnell LR; Schreier P; Stein R; Kubánková M; Guck J; Hackstein H; Alexiou C; Janko C
    Front Immunol; 2023; 14():1223695. PubMed ID: 37662937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loading of Primary Human T Lymphocytes with Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles Does Not Impair Their Activation after Polyclonal Stimulation.
    Mühlberger M; Unterweger H; Band J; Lehmann C; Heger L; Dudziak D; Alexiou C; Lee G; Janko C
    Cells; 2020 Feb; 9(2):. PubMed ID: 32024193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles Enable a Stable Non-Spilling Loading of T Cells and Their Magnetic Accumulation.
    Boosz P; Pfister F; Stein R; Friedrich B; Fester L; Band J; Mühlberger M; Schreiber E; Lyer S; Dudziak D; Alexiou C; Janko C
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalization Of T Lymphocytes With Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles For Magnetically Controlled Immune Therapy.
    Mühlberger M; Janko C; Unterweger H; Friedrich RP; Friedrich B; Band J; Cebulla N; Alexiou C; Dudziak D; Lee G; Tietze R
    Int J Nanomedicine; 2019; 14():8421-8432. PubMed ID: 31749616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superparamagnetic Iron Oxide Nanoparticles Reprogram the Tumor Microenvironment and Reduce Lung Cancer Regrowth after Crizotinib Treatment.
    Horvat NK; Chocarro S; Marques O; Bauer TA; Qiu R; Diaz-Jimenez A; Helm B; Chen Y; Sawall S; Sparla R; Su L; Klingmüller U; Barz M; Hentze MW; Sotillo R; Muckenthaler MU
    ACS Nano; 2024 Apr; 18(17):11025-11041. PubMed ID: 38626916
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Hunger J; Schregel K; Boztepe B; Agardy DA; Turco V; Karimian-Jazi K; Weidenfeld I; Streibel Y; Fischer M; Sturm V; Santarella-Mellwig R; Kilian M; Jähne K; Sahm K; Wick W; Bunse L; Heiland S; Bunse T; Bendszus M; Platten M; Breckwoldt MO
    Theranostics; 2023; 13(15):5170-5182. PubMed ID: 37908732
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell Viability and Immunogenic Function of T Cells Loaded with Nanoparticles for Spatial Guidance in Magnetic Fields.
    Pfister F; Alexiou C; Janko C
    Methods Mol Biol; 2023; 2644():331-346. PubMed ID: 37142932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells.
    Cicha I; Scheffler L; Ebenau A; Lyer S; Alexiou C; Goppelt-Struebe M
    Nanotoxicology; 2016; 10(5):557-66. PubMed ID: 26468004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1.
    Jahn L; Hombrink P; Hagedoorn RS; Kester MG; van der Steen DM; Rodriguez T; Pentcheva-Hoang T; de Ru AH; Schoonakker MP; Meeuwsen MH; Griffioen M; van Veelen PA; Falkenburg JH; Heemskerk MH
    Blood; 2017 Mar; 129(10):1284-1295. PubMed ID: 28053195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyapatite as a Vehicle for the Selective Effect of Superparamagnetic Iron Oxide Nanoparticles against Human Glioblastoma Cells.
    Pernal S; Wu VM; Uskoković V
    ACS Appl Mater Interfaces; 2017 Nov; 9(45):39283-39302. PubMed ID: 29058880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
    Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
    Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avidity characterization of genetically engineered T-cells with novel and established approaches.
    Hillerdal V; Boura VF; Björkelund H; Andersson K; Essand M
    BMC Immunol; 2016 Jul; 17(1):23. PubMed ID: 27411667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles.
    Kalber TL; Ordidge KL; Southern P; Loebinger MR; Kyrtatos PG; Pankhurst QA; Lythgoe MF; Janes SM
    Int J Nanomedicine; 2016; 11():1973-83. PubMed ID: 27274229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic motion of superparamagnetic iron oxide nanoparticles- loaded dental adhesives: physicochemical/biological properties, and dentin bonding performance studied through the tooth pulpal pressure model.
    Garcia IM; Balhaddad AA; Lan Y; Simionato A; Ibrahim MS; Weir MD; Masri R; Xu HHK; Collares FM; Melo MAS
    Acta Biomater; 2021 Oct; 134():337-347. PubMed ID: 34303014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer Coated Iron Nanoparticles: Radiolabeling & In vitro Studies.
    Yilmaz S; Ichedef C; Karatay KB; Teksöz S
    Curr Radiopharm; 2021; 14(1):37-45. PubMed ID: 32351192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetically Enhanced Intracellular Uptake of Superparamagnetic Iron Oxide Nanoparticles for Antitumor Therapy.
    Choi J; Kim DI; Kim JY; Pané S; Nelson BJ; Chang YT; Choi H
    ACS Nano; 2023 Aug; 17(16):15857-15870. PubMed ID: 37477428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion.
    Morton LT; Wachsmann TLA; Meeuwsen MH; Wouters AK; Remst DFG; van Loenen MM; Falkenburg JHF; Heemskerk MHM
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
    Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
    Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles.
    Gui G; Fan Z; Ning Y; Yuan C; Zhang B; Xu Q
    Int J Nanomedicine; 2021; 16():2283-2295. PubMed ID: 33776433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid Tumor Microenvironment Can Harbor and Support Functional Properties of Memory T Cells.
    Sullivan PM; Reed SJ; Kalia V; Sarkar S
    Front Immunol; 2021; 12():706150. PubMed ID: 34867942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.